Dual diagnosis in an inpatient drug-abuse detoxification unit

European Addiction Research

Volumn 13, Issue 4, 2007, Pages 192-200

  Nocon, Agnes ^a   Bergé, Daniel ^a   Astals, Mónica ^a,b   Martín Santos, Rocío ^a   Torrens, Marta ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Co morbidity; Detoxification; Dual diagnosis; General hospital; Illegal drugs; Mental disorders; Substance use disorders

Indexed keywords

CANNABIS; ILLICIT DRUG; SEDATIVE AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG ABUSE; DRUG DETOXIFICATION; FEMALE; GENERAL HOSPITAL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL DISEASE; MENTAL PATIENT; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY; SOCIAL PSYCHOLOGY; UNIVERSITY HOSPITAL;

ADULT; ALCOHOLISM; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; SOCIAL ADJUSTMENT; SPAIN; STREET DRUGS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 34548699900     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104881     Document Type: Article

References (45)

1. Havassy BE, Alvidrez J, Owen KK: Comparisons of patients with co-morbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry 2004;161:139-145.
2. Pettinati HM, Pierce JD Jr, Belden PP, Meyers K: The relationship of axis II personality disorders to other known predictors of addiction treatment outcome. Am J Addict 1999;8:136-147.
3. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE: Psychiatric and substance use co-morbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71-80.
4. Chen CC, Tsai SY, Su LW, Yang TW, Tsai CJ, Hwu HG: Psychiatric co-morbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction 1999;94:825-832.
5. Compton WM III, Cottler LB, Jacobs JL, Ben Abdallah A, Spitznagel EL: The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry 2003;160:890-895.
6. Craig TJ, DiBuono M: Recognition of comorbid psychopathology by staff of a drug detoxification unit. Am J Addict 1996;5:76-80.
7. Kraus L, Muller-Kalthoff T: Psychosoziale Belastung bei Drogentoten. [Psychosocial stress preceding drug-related deaths]. Gesundheitswesen 2002;64:548-553.
8. Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C: Personality disorders in drug abusers: prevalence and their association with axis I disorders as predictors of treatment retention. Addict Behav 1998;23:841-853.
9. Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK: Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004;74:115-122.
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, APA, 1994.
11. Haro G, Mateu C, Martinez-Raga J, Valderrama JC, Castellano M, Cervera G: The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification. Eur Psychiatry 2004;19:187-192.
12. San L, Cami J, Peri JM, Mata R, Porta M: Success and failure at inpatient heroin detoxification. Br J Addict 1989;84:81-87.
13. Perez de los Cobos Peris JC: El problema de los trastornos psiquiatricos concomitantes en las drogodependencias de opiaceos y cocaina. [The problem of psychiatric disorders associated with dependence on opiates and cocaine (review)]. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1988;16:37-48.
14. Torrens M, San L, Peri JM, Olle JM: Cocaine abuse among heroin addicts in Spain. Drug Alcohol Depend 1991;27:29-34.
15. Foy A, March S, Drinkwater V: Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res 1988;12:360-364.
16. Busto UE, Sykora K, Sellers EM: A clinical scale to assess benzodiazepine withdrawal. J Clin Psychopharmacol 1989;9:412-416.
17. Gossop M: The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990;15:487-490.
18. Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, Weinrieb RM, O'Brien CP: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav 2002;27:251-260.
19. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R: Diagnosis of co-morbid disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSMIV. Am J Psychiatry 2006;163:689-696.
20. Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R: Diagnosing co-morbid psychiatric disorders in substance abusers: validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSMIV. Am J Psychiatry 2004;161:1231-1237.
21. SPSS Inc: SPSS 10.0 for Windows. Munich, SPSS Inc, 2000.
22. Stata Corporation: Stata Statistical Software: Release 7. College Station/TX, Stata Corp LP, 2001.
23. Franken IH, Hendriks VM: Predicting outcome of inpatient detoxification of substance abusers. Psychiatr Serv 1999;50:813-817.
24. Hendriks VM: Psychiatric disorders in a Dutch addict population - rates and correlates of DSM-III diagnosis. J Consult Clin Psychol 1990;58:158-165.
25. Franken IH, Hendriks VM: Early-onset of illicit substance use is associated with greater axis-II co-morbidity, not with axis-I co-morbidity. Drug Alcohol Depend 2000;59:305-308.
26. Astals M, Torrens M, Domingo-Salvany A, Tato J, Vazquez JM, Martín-Santos R, Castillo C: Health-related quality of life and non-substance use psychiatric disorders in methadone maintenance treatment. Subst Use Misuse 2006 (in press).
27. Rodríguez-Llera MC, Domingo-Salvany A, Brugal MT, Silva TC, Sánchez-Niubó A, Torrens M: Psychiatric co-morbidity in young heroin users. Drug Alcohol Depend 2006;84:48-55.
28. Verheul R: Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry 2001;16:274-282.
29. Hien D, Scheier J: Trauma and short-term outcome for women in detoxification. J Subst Abuse Treat 1996;13:227-231.
30. Perez de los Cobos J, Trujols J, Ribalta E, Casas M: Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. Am J Drug Alcohol Abuse 1997;23:267-279.
31. McCusker J, Bigelow C, Luippold R, Zorn M, Lewis BF: Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am J Drug Alcohol Abuse 1995;21:1-16.
32. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M: Psychiatric symptoms among clients seeking treatment for drug dependence - Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000;176:285-289.
33. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD: The relationship of psychiatric co-morbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001;61:271-280.
34. Krausz M, Degkwitz P, Kuhne A, Verthein U: Co-morbidity of opiate dependence and mental disorders. Addict Behav 1998;23:767-783.
35. Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ: Co-occurrence of axis I and axis II disorders in substance abusers. Acta Psychiatr Scand 2000;101:110-118.
36. Carroll KM, Power ME, Bryant K, Rounsaville BJ: One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993;181:71-79.
37. Krausz M, Verthein U, Degkwitz P: Psychiatric co-morbidity in opiate addicts. Eur Addict Res 1999;5:55-62.
38. Weiss RD, Martinez-Raga J, Hufford C: The significance of a coexisting opioid use disorder in cocaine dependence: an empirical study. Am J Drug Alcohol Abuse 1996;22:173-184.
39. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE: Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987;44:505-513.
40. Rounsaville BJ, Kleber HD: Untreated opiate addicts. How do they differ from those seeking treatment? Arch Gen Psychiatry 1985;42:1072-1077.
41. Woody GE, McLellan AT, Luborsky L, O'Brien CP: Sociopathy and psychotherapy outcome. Arch Gen Psychiatry 1985;42:1081-1086.
42. Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML: One-, three-, and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse 2001;27:19-44.
43. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA: Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-625.
44. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD: Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry 1986;43:739-745.
45. Direcció General de Drogodependències i SIDA: Informe anual 2001. Barcelona, Generalitat de Catalunya, 2002.